Basic Materials Stocks on the Move Friday IAG, GLATF, CDE, EXK, SNES, SVFD, ICL, CENX - InvestorsObserver
| ICL Stock | ILA 1,640 34.00 2.03% |
About 62% of ICL Israel's investor base is looking to short. The analysis of current outlook of investing in ICL Israel Chemicals suggests that many traders are alarmed regarding ICL Israel's prospects. The current market sentiment, together with ICL Israel's historical and current headlines, can help investors time the market. In addition, many technical investors use ICL Israel Chemicals stock news signals to limit their universe of possible portfolio assets.
ICL |
Basic Materials Stocks on the Move Friday IAG, GLATF, CDE, EXK, SNES, SVFD, ICL, CENX InvestorsObserver
Read at news.google.com
 |
ICL Israel Fundamental Analysis
We analyze ICL Israel's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
ICL Israel is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
ICL Israel Chemicals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ICL Israel stock to make a market-neutral strategy. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics with similar companies.
Peers
ICL Israel Related Equities
| BEZQ | Bezeq Israeli | 0.75 | ||||
| TEVA | Teva Pharmaceutical | 1.06 | ||||
| POLI | Bank Hapoalim | 1.56 | ||||
| ESLT | Elbit Systems | 2.02 | ||||
| LUMI | Bank Leumi | 2.11 |
Complementary Tools for ICL Stock analysis
When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |